Tag: FDA

4As CHC healthcare marketing summit 10-9-25

What Pharma Can Teach Every Marketer About Risk, Regulation and Trust

FDA-headquarters

Summary, Analysis and Recommendations on the Administration’s Announcements to Limit Rx Ads

Dr. Marty Makary

Here’s the 411 on FDA Commissioner Nominee Martin Makary, MD, MPH

slide_Legislative1

Post-Election Healthcare Update: What the 2024 Elections Mean for the Policy Landscape Regulating Healthcare Marketers and Publishers

Sen. John Thune

2025 Congressional Leadership on Healthcare Issues

FDA-headquarters

Current FDA Voluntary Pre-Publication Rx Ad Review Processes

FDA-headquarters

FDA Issues Long-Awaited Final Rule for DTC Prescription Drug Ads

FTC Building for CHC Washington Insider Mast Head 5-23

FTC Proposes Changes to Health Breach Notification Rule to Strengthen Health App Applicability

FTC Building for CHC Washington Insider Mast Head 5-23

4A’s Submits Comments to FTC on Environmental Claims in Marketing (i.e. “Green Guides”)